Relx PLC
XMUN:RDED
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Relx PLC
XMUN:RDED
|
UK |
|
L
|
Lonza Group AG
XMUN:LO3
|
CH |
|
V
|
Vertex Pharmaceuticals Inc
DUS:VX1
|
US |
Wall St Price Targets
RDED Price Targets Summary
Relx PLC
According to Wall Street analysts, the average 1-year price target for RDED is 43.14 EUR with a low forecast of 34.39 EUR and a high forecast of 66.02 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RDED's stock price target?
Price Target
43.14
EUR
According to Wall Street analysts, the average 1-year price target for RDED is 43.14 EUR with a low forecast of 34.39 EUR and a high forecast of 66.02 EUR.
What is the Revenue forecast for Relx PLC?
Projected CAGR
7%
Over the last 2 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 3 years is 7%.
What is the Gross Profit forecast for Relx PLC?
Projected CAGR
7%
Over the last 2 years, the compound annual growth rate for Gross Profit has been 3%. The projected CAGR for the next 3 years is 7%.
What is the Operating Income forecast for Relx PLC?
Projected CAGR
12%
Over the last 2 years, the compound annual growth rate for Operating Income has been 6%. The projected CAGR for the next 3 years is 12%.
What is the Pre-Tax Income forecast for Relx PLC?
Projected CAGR
12%
Over the last 2 years, the compound annual growth rate for Pre-Tax Income has been 9%. The projected CAGR for the next 3 years is 12%.
What is the Net Income forecast for Relx PLC?
Projected CAGR
14%
Over the last 2 years, the compound annual growth rate for Net Income has been 8%. The projected CAGR for the next 3 years is 14%.
